Suppr超能文献

[肾细胞癌根治性肾切除术的结果。报告1。根据肾细胞癌临床和病理研究总则的TNM分期系统进行分析]

[Results of radical nephrectomy for renal cell carcinoma. Report 1. Analysis according to the TNM staging system of the general rule for clinical and pathological studies on renal cell carcinoma].

作者信息

Nishio Y, Nishimura K, Hida S, Okada Y, Takeuchi H, Miyakawa M, Okada K, Yoshida O

出版信息

Hinyokika Kiyo. 1987 Mar;33(3):337-43.

PMID:3618401
Abstract

One hundred and six patients with renal cell carcinoma were treated with radical nephrectomy at our Department between 1970 to December, 1985. A retrospective analysis was performed with TNM staging system of The General Rule for Clinical and Pathological Studies on Renal Cell Carcinoma, which was established by the Japanese Urological Association in 1983. The 5-year survival rate according to pathological T-stage was 100% for 2 patients in pT1, 67.5% for 58 patients in pT2, 49.5% for 42 patients in pT3, 0% for 4 patients in pT4. Two patients in stage of pT1 had no venous involvement, lymph node metastasis, or distant metastasis. Twenty two patients had positive venous involvement (21%), 4 (7%) in stage of pT2, 16 (38%) in pT3, 2 (50%) in pT4. Twelve patients had positive lymph nodes (11%), 0 (0%) in stage of pT2, 10 (24%) in pT3, 2 (50%) in pT4. Twenty five patients, (24%) had distant metastasis at the time of nephrectomy, 8 (14%) in stage of pT2, 15 (38%) in pT3, 2 (50%) in pT4. The 5-year survival of 22 patients with venous involvement, 12 patients with lymph nodes metastasis, 25 patients with distant metastasis were 47%, 30%, 39% respectively. No significant difference of 5-year survival between 69% of 48 patients in T1 & 2VoNoMo (Robson-I) and 76% of 12 patients in T3VoNoMo (Robson-II) were considered to need the establishment of new classification for early stage of renal cell carcinoma. TNM staging system was thought to be better than Robson's Classification for analyzing the unique biological potential of renal cell carcinoma.

摘要

1970年至1985年12月期间,我科对106例肾细胞癌患者实施了根治性肾切除术。采用日本泌尿外科学会于1983年制定的《肾细胞癌临床与病理研究总则》的TNM分期系统进行回顾性分析。根据病理T分期,pT1期的2例患者5年生存率为100%,pT2期的58例患者为67.5%,pT3期的42例患者为49.5%,pT4期的4例患者为0%。pT1期的2例患者无静脉侵犯、淋巴结转移或远处转移。22例患者有静脉侵犯阳性(21%),pT2期4例(7%),pT3期16例(38%),pT4期2例(50%)。12例患者有淋巴结阳性(11%),pT2期0例(0%),pT3期10例(24%),pT4期2例(50%)。25例患者(24%)在肾切除时已有远处转移,pT2期8例(14%),pT3期15例(38%),pT4期2例(50%)。22例有静脉侵犯患者、12例有淋巴结转移患者、25例有远处转移患者的5年生存率分别为47%、30%、39%。T1&2VoNoMo(Robson-I)期48例患者中的69%与T3VoNoMo(Robson-II)期12例患者中的76%的5年生存率无显著差异,认为需要建立肾细胞癌早期的新分类。TNM分期系统在分析肾细胞癌独特的生物学潜能方面被认为优于Robson分类法。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验